September audit deficiency trends. acuitas, inc. concluding thoughts. pcaob s audit deficiencies by audit standard.
|
|
- Moses Caldwell
- 6 years ago
- Views:
Transcription
1 September 2015 home executive summary audit deficiencies pcaob inspections methodology are still significant description of a deficiency audit deficiency trends fvm deficiencies impairment deficiencies pcaob s audit deficiencies by audit standard concluding thoughts acuitas, inc.
2 Executive Summary Public Company Accounting Oversight Board ( PCAOB ) inspection reports provide insight into recent audit quality trends. Acuitas, Inc. s Survey of Fair Value Audit Deficiencies ( Survey ) is intended to assist financial statement preparers, auditors, and valuation specialists in understanding the underlying causes of fair value measurement ( FVM ) and impairment audit deficiencies, as reported by the PCAOB. There are a number of key findings and trends that were gleaned from the 2008 to 2013 inspection reports. 43% of all audits inspected by the PCAOB had deficiencies in This rate has steadily increased from 2009 when the PCAOB found deficiencies in only 16.0% of the audits reviewed. FVM audit deficiencies continue to be significant, making up 21.5% of total deficiencies for annually inspected firms in The PCAOB cited substantive failures associated with AU 328 Auditing Fair Value Measurement and Disclosures in 10.3% of the deficient audits in FVM audit deficiencies are increasingly attributable to business combination engagements. The incidence FVM deficiencies related to business combinations jumped from an average of 9% for 2008 through 2011 to 45% in 2012 and increased further to 49% in This trend is likely caused by a rebound in merger and acquisition activity as the economy continues its recovery. The number of deficiencies cited by the PCAOB caused solely by failures to assess risk and test internal controls increased sharply in 2012 and remains high in 2013 at 45% of all deficiencies for the top 25 firms. These risk assessment and control deficiencies caused 45.3% of the FVM deficiencies and 32.3% of impairment deficiencies cited by the PCAOB in This is a significant shift from earlier years when FVM deficiencies were primarily caused by inadequate substantive testing of asset prices and impairment deficiencies were primarily caused by inadequate substantive testing of management s prospective financial information ( PFI ). 1
3 FVM Audit Deficiencies Continue To Be Significant Audit deficiencies attributable to FVM and impairment engagements continue to be significant and made up approximately one third of all audit deficiencies in The purpose of the Survey is to help financial statement preparers, auditors, and valuation specialists understand the ultimate causes of FVM and impairment audit deficiencies and failures, according to the PCAOB. The purpose is also to highlight trends in the PCAOB inspection findings, in aggregate. The information contained in the study should be of benefit not only to public entities and their auditors, but by extension, to private entities and their auditors. The survey begins with a brief overview of the PCAOB inspection process, our survey methodology and a description of an audit deficiency. It examines trends in audit deficiencies by looking at statistics over a six year period. Another section of the survey provides information about the specific causes of FVM and impairment audit deficiencies. A final section summarizes the PCAOB s break down of 2013 audit deficiencies by auditing standard. PCAOB Inspections The PCAOB conducts inspections of registered public accounting firms as required by the Sarbanes-Oxley Act of The inspections are designed to identify and address deficiencies in a firm s audit engagements and to determine whether deficiencies indicate a weakness or defect in the firm s system of quality control over audits. The annual inspection process encompasses a review of selected audits and a review of the firm s system for quality control. PCAOB reviews of selected audits are intended to identify financial statement misstatements, including failures to comply with disclosure requirements and failures to perform applicable audit procedures. When a deficiency reaches a level of significance that appears to indicate the firm failed to obtain sufficient audit evidence to support its audit opinion on the financial statements or on the effectiveness of internal control over financial reporting, the deficiency is described in the PCAOB s inspection report, which is publicly available. The PCAOB performs annual inspections of firms that regularly provide audit reports for more than 100 issuers. The largest international auditing firms, Deloitte & Touche LLP, Ernst & Young LLP, KPMG LLP and PricewaterhouseCoopers LLP ( the Big Four ) are among the nine firms inspected annually. 1 The PCAOB conducts inspections triennially (once every three years) of smaller auditing firms that audit public registrants. While the PCAOB inspection reports are silent about the financial statement dates of the audit engagements examined, the PCAOB s field work generally begins just after the audit season in February or March, and extends through October or November. Therefore, it appears likely that 2013 inspection reports relate to audits of 2012 financial statements. 1 The remaining firms are McGladrey LLP, Grant Thornton LLP, MaloneBailey, LLP, Crowe Horwath LLP and BDO USA, LLP. 2
4 Methodology The Survey of Fair Value Audit Deficiencies from PCAOB Inspection Reports was prepared using a twofold approach. First, we examined the PCAOB s inspection reports for firms subject to annual inspection. In order to analyze trends in audit deficiencies, we focused on the nine firms with inspection reports available each year from 2008 through The nine firms include Deloitte & Touche LLP, Ernst & Young LLP, KPMG LLP, PricewaterhouseCoopers LLP, McGladrey LLP, Grant Thornton LLP, BDO USA LLP, MaloneBailey, LLP and Crowe Horwath LLP. The PCAOB performed field work at each of these nine firms national offices and in 172 (35.8%) of the firms practice offices, and reviewed aspects of 308 audits and 6 other engagements. Our summary of PCAOB findings appears in the section entitled Audit Deficiency Trends. The purpose of the second part of our survey is to analyze the types of engagements that give rise to FVM and impairment deficiencies and to examine the causes of these deficiencies. The second part of the survey covers all of the PCAOB inspection reports available for the top 25 public accounting firms 2 for 2008 through 2013, including those subject to annual inspection and those subject to inspection every three years. Of the 96 available inspection reports, 64 (66.7%) had FVM and impairment audit deficiencies. The PCAOB provides a brief description of the type of audit failure and the underlying cause. For each report, the PCAOB generally presents each deficiency as a separate bullet point. Acuitas counts and categorizes each deficiency based on the type of audit failure. FVM deficiency categories include financial instruments, pension plans and business combinations, and impairment deficiency categories include those attributable to goodwill, asset groups and intangible assets. The underlying causes were tallied and audit deficiency statistics were calculated. Description of a Deficiency The individual PCAOB inspection reports themselves do not define deficiency. However, Auditing Standard No. 7 Engagement Quality Review provides a description, saying that a significant audit engagement deficiency exists when (1) the engagement team failed to obtain sufficient appropriate evidence in accordance with the standards of the PCAOB, (2) the engagement team reached an inappropriate overall conclusion on the subject matter of the engagement, (3) the engagement report is not appropriate in the circumstances, or (4) the firm is not independent of its client. 3 2 The 2015 accountingtoday Top 100 Firms, 3 PCAOB Auditing Standard No. 7 Engagement Quality Review 3
5 Audit Deficiency Trends The PCAOB inspections for annually inspected firms from 2008 through 2013 indicate several trends. First, the percentage of audit engagements with deficiencies has increased dramatically since and remains high. In connection with the nine 2013 annual inspections, the PCAOB found deficiencies in 132 issuers, or 42.9% of audits and other engagements examined which is similar to 2012 inspections. In 2009, the inspection reports for the same nine firms cited deficiencies in 61 issuers, or 16.0% of audits examined 50.0% PCAOB Annually Inspected Firms 40.0% 30.0% 20.0% 10.0% 0.0% % of Engagements with Deficiencies 4 The percentage of audit engagements with deficiencies is not available for
6 A second trend indicates that FVM and impairment deficiencies have declined for the annually inspected firms since their peak in 2010 while other deficiencies increased and remained high. In 2010, there were 126 FVM and 40 impairment deficiencies, representing 48.4% of all deficiencies and in 2013 there were 70 FVM and 31 impairment deficiencies, representing 31.0% of total deficiencies. Deficiency Trends Number of Deficiencies FVM Deficiencies Impairment Deficiencies Other Deficiencies A third trend is the increase in the number of deficiencies cited by the PCAOB caused by failures to assess risk and test internal controls. These risk and control deficiencies increased sharply in 2012 and remain high in Risk assessment and control deficiencies caused 45.3% of the FVM deficiencies and 32.3% of impairment deficiencies cited by the PCAOB in 2013 for the top 25 audit firms. FVM and impairment deficiencies are discussed at length in the next sections of the survey. The PCAOB s recent emphasis on risk assessment and testing internal controls can also be seen in the breakdown of audit deficiencies for other types of audit failures. Substantive testing failures alone account for only 26% of audit failures while risk assessment and control testing failures contribute to 74% of audit failures Other Deficiency Causes 26% 26% 48% Risk Assessment & Control Testing Substantive Testing Both 5
7 FVM Deficiencies In all six years, FVM deficiencies were primarily attributable to financial instruments; however the percentage decreased from 80% in prior years to 51% in Business combinations were the source of an average of 17% of FVM deficiencies in prior years; however, deficiencies related to business combinations increased substantially to 49% of all FVM deficiencies in These trends are likely caused by audit improvements for financial instruments that resulted from the PCAOB inspection process and by increased merger activity in recent years FVM Deficiencies 2008 to 2012 FVM Deficiencies 3% 49% 17% 51% 80% Financial Instruments Business Combinations Financial Instruments Business Combinations Pension Plans While pricing deficiencies and failures to adequately perform substantive tests were the primary causes of FVM failures in earlier years, a new deficiency trend was observed in 2012 and In recent inspection reports, there were many instances where the PCAOB cited audit deficiencies relating to testing internal controls over FVM without citing a related substantive testing deficiency. This internal control trend for FVM is consistent with all other aspects of financial reporting. In the 2013 inspection reports, the PCAOB indicated that 45.3% of FVM deficiencies, 32.3% of impairment deficiencies and 48.0% of other deficiencies were primarily caused by failures to assess risk and identify and / or test internal controls. The following are typical examples of deficiencies related to internal controls cited by the PCAOB. The Firm selected for testing only one control, a review control, over the valuation of investment securities. The Firm s procedures to test this control were limited to observing the evidence that the review had occurred, without evaluating whether the control operated a t a level of precision that would prevent or detect material misstatements related to the valuation of the investment securities. 6
8 The Firm s tests of certain review controls over the accounting for business combinations were insufficient. Specifically, the Firm s procedures were limited to observing evidence of reviewer sign-off, without evaluating whether the controls operated at a level of precision that would prevent or detect material misstatements. More specific descriptions of these FVM audit deficiencies taken from the PCAOB inspection reports are provided in the insert on the following page FVM Deficiency Causes 2008 to 2012 FVM Deficiency Causes 45% 15% 13% 19% 8% Pricing Failure to Test Disclosures Risk Assessment/ Controls PFI Assumptions 22% 4% 7% 9% 23% 35% Pricing Failure to Test Disclosures Risk Assessment/ Controls PFI Assumptions OTTI Classification 7
9 Descriptions of Fair Value Measurement Deficiencies Pricing Includes failure to understand the methods, models and assumptions used by pricing services or valuation specialists; using the same pricing service to corroborate prices that the issuer used when measuring fair value; failure to investigate significant differences between prices from different sources; failure to investigate pricing differences identified by internal audit; failure to investigate adjustments made to third party prices by issuers; and inappropriately applying the yield or discount rate from one population to test securities prices or values in the test population without assessing the comparability of the two groups. Failure to Test Includes relying on interim testing and failing to test the assertion there was no material change in value; relying on interim testing and failing to perform procedures at year end; failing to perform sufficient substantive procedures when significant risks are identified; failing to perform year end tests when broker quotes were older than 30 days; failing to perform substantive tests when too much reliance is placed on internal controls or internal audit; failure to assess whether all assets and liabilities had been identified in a business combination; failure to test data provided to outside valuation specialist; failure to test the accuracy and completeness of data that valuation specialists relied on; failure to test fair value when requested pricing information was not received; failure to test all items in a selected sample; and outright failure to test certain assets and liabilities. Disclosures Includes failure to identify and test controls over FVM hierarchy disclosures; failure to test FVM hierarchy classification as Level 2 or Level 3; and failure to assess whether an input is observable or unobservable when testing the FVM hierarchy classification. Risk Assessment / Controls Includes the failure to identify and test controls over inputs to FVMs; setting risk thresholds so high that material errors are not detected; failure to investigate controls over resolution of pricing differences; failure to identify weakness due to lack of supervision by qualified personnel in the testing of hard-to-value financial instruments; failure to test controls over the budgetary process; and failure to test controls over the classification of securities as available for sale. Projected Financial Information (PFI) Assumptions Includes failure to evaluate the reasonableness of assumptions relating to revenue growth rates, capital expenditures, terminal growth rates and the discount rate; failure to assess the reasonableness of improved margins; failure to consider industry growth rates; erroneously using PFI from a period prior to a reorganization; failure to evaluate customer attrition rates; failure to evaluate the risk premium in the issuer s weighted average cost of capital; failure to evaluate a significant difference between value indications from the market and income approaches; and failure to assess a change in weights assigned to various indications of value. Other Than Temporary Impairment (OTTI) Includes failure to test controls over the classification of securities as OTTI; failure to test the issuers evaluation of securities as potentially OTTI; and failure to evaluate the assumptions, calculations and completeness of the issuer s OTTI test. 8
10 Impairment Deficiencies While the number of impairment deficiencies has remained relatively flat since 2011, they were dominated by those related to goodwill impairments with 48.4% in 2013, and 54.4% in 2008 to Most of the remaining impairment deficiencies relate to long lived asset groups. The incidence of deficiencies relating solely to the impairment of intangible assets was 16.1% in Impairment Deficiencies 2008 to 2012 Impairment Deficiencies 16% Goodwill 11% Goodwill 36% 48% Long Lived Asset Groups Intangible Assets 35% 54% Long Lived Asset Groups Intangible Assets The underlying causes of audit deficiencies related to impairment testing highlights the PCAOB s recent emphasis on risk assessment and testing internal controls. In 2013, 32.3% of impairment deficiencies were caused by failures to assess risk and test internal controls. The graph for 2008 to 2012 understates this trend as 50% of impairment deficiencies were caused by internal control failures in 2012, up from 21% in all previous years. The PCAOB s focus on internal control deficiencies for impairment testing is similar to the trend observed for FVM deficiencies. More specific descriptions of these impairment audit deficiencies taken from the PCAOB inspection reports are provided following the Impairment Deficiency Causes graphs Impairment Deficiency Causes 2008 to 2012 Impairment Deficiency Causes PFI Assumptions 5% PFI Assumptions 32% 36% Risk Assessment/ Controls Failure to Test 24% 43% Risk Assessment/ Controls Failure to Test 32% 28% Asset Mismatch 9
11 Descriptions of Impairment Deficiencies PFI Assumptions In addition to the PFI assumption deficiencies mentioned for FVM, a deficiency relating to the failure to test the model, inputs and assumptions used to value a loan portfolio in connection with a goodwill impairment analysis was identified. Risk Assessment / Controls Additional deficiencies were failure to assess the issuer s methodology for determining fair value of reporting units, failure to identify deficiencies in controls relating to triggering events; and failure to assess whether the timing of impairment charge was appropriate. Failure to Test An additional deficiency was failure to test the issuer s assertion that assets were not impaired and ignoring evidence that triggering events had occurred. Asset Mismatch Including failure to identify a mismatch between the group of assets being tested for impairment and the group of assets included in the calculation of carrying value; and failure to identify an issuer s departure from GAAP by allocating goodwill to reporting units. 10
12 PCAOB Audit Deficiencies by Audit Standard In its reports, the PCAOB emphasizes that deficiencies represent circumstances when the firm failed to obtain sufficient appropriate evidence to support its opinion that; 1) the financial statements were presented fairly, in all material respects, in accordance with applicable accounting principles, and/or 2) the issuer maintained, in all material respects, effective internal controls over financial reporting. Furthermore, the PCAOB indicates that audit deficiencies involve the lack of due professional care in the planning and performance of audit work. According to the PCAOB, audit failures are caused by a critical absence of due professional care which requires that auditors apply professional skepticism to assess the appropriateness and sufficiency of audit evidence taking into consideration the risk of material misstatement, the risk mitigated by controls and the relevance and reliability of audit evidence. In connection with its 2013 inspection reports, the PCAOB provides references to specific auditing standards for each deficiency cited. These references to auditing standards are summarized in the following graph Audit Deficiencies by Auditing Standard AS No. 5 - Audit of Internal Control 3.6% 2.9%2.7% 3.9% 6.0% 10.3% 11.5% 16.4% 40.5% AS No Risk of Material Misstatement AU Audit Sampling AU Auditing FVM & Disclosures AU Auditing Estimates AS No Evaluating Audit Results AU Substantive Analytic Procedures AS No Audit Evidence AU Considering Internal Audit AS - Other AU - Other 11
13 Concluding Thoughts Based on our analysis of PCAOB inspection reports, it is apparent that the number of audits with deficiencies remains high. Consistent with our findings in prior surveys, a significant number of these deficiencies relate to the auditing of fair value measurements and impairment testing. In early PCAOB inspection reports, audit failures were primarily attributable to deficiencies in the fair value measurement of financial instruments caused by pricing problems and failure to adequately test the value. More recent inspection reports indicate a significant drop in deficiencies related to financial instruments to 51.4% and an increase in the number of deficiencies related to business combinations to 48.6%. Meanwhile, there has been a significant shift in the primary cause of FVM deficiencies. FVM failures are now primarily attributable to failures to assess risk and test internal controls. The number of impairment deficiencies and the relative numbers of goodwill, intangible asset and asset group impairment deficiencies cited by the PCAOB has remained fairly constant for the last three years. However, the number of deficiencies caused by failures to properly assess risks and to test the controls related to impairment has increased since 2011, consistent with our observations for FVM risk assessment and controls. While professional judgment is required in both the audit engagements and the PCAOB inspection process, professionals may reach different conclusions as to the adequacy of the audit process. PCAOB inspection deficiencies relate to the audit process where the deficiencies were of such significance that the firm failed to obtain sufficient appropriate audit evidence to support its audit opinion on the financial statements and / or the effectiveness of internal control. This survey is a summary of publicly available information, the purpose of which is to hightlight trends in audit deficiencies related to fair value measurements and impairments. A more complete presentation of the underlying data can be found in the inspection report themselves. Acuitas, Inc. Acuitas, Inc. is an Atlanta, Georgia based valuation and decision consulting firm. Additional information about our firm can be found at For more information about how Acuitas, Inc. can assist with valuation-related services, please contact Mark Zyla, Managing Director at or mzyla@acuitasinc.com. 12
IAASB Main Agenda (September 2005) Page Agenda Item. Analysis of ISA 330 and Mapping Document
IAASB Main Agenda (September 2005 Page 2005 1869 Agenda Item 4-D.1 Analysis of ISA 330 and Mapping Document 1. Exhibit 1 sets out statements in ISA 330 that use the present tense to describe auditor actions,
More informationISA 540, Auditing Accounting Estimates, Including Fair Value Accounting Estimates, and Related Disclosures Issues and Task Force Recommendations
Agenda Item 1-A ISA 540, Auditing Accounting Estimates, Including Fair Value Accounting Estimates, and Related Disclosures Issues and Task Force Recommendations Introduction 1. Since the September 2016
More informationIAASB Main Agenda (February 2007) Page Agenda Item PROPOSED INTERNATIONAL STANDARD ON AUDITING 530 (REDRAFTED)
IAASB Main Agenda (February 2007) Page 2007 423 Agenda Item 6-A PROPOSED INTERNATIONAL STANDARD ON AUDITING 530 (REDRAFTED) AUDIT SAMPLING AND OTHER MEANS OF TESTING CONTENTS Paragraph Introduction Scope
More informationINTERNATIONAL STANDARD ON ASSURANCE ENGAGEMENTS 3000 ASSURANCE ENGAGEMENTS OTHER THAN AUDITS OR REVIEWS OF HISTORICAL FINANCIAL INFORMATION CONTENTS
INTERNATIONAL STANDARD ON ASSURANCE ENGAGEMENTS 3000 ASSURANCE ENGAGEMENTS OTHER THAN AUDITS OR REVIEWS OF HISTORICAL FINANCIAL INFORMATION (Effective for assurance reports dated on or after January 1,
More information5/27/15. Instructor Michael Brownlee B.Comm(Hons),CGA Course AU1. Exam 3 hours Wednesday eve 6:30-9:30pm June 11 check your schedule
Instructor Michael Brownlee B.Comm(Hons),CGA Course AU1 Exam 3 hours Wednesday eve 6:30-9:30pm June 11 check your schedule Key areas for Modules 1 through 10 Focus on Control objectives Focus on Assertions/procedures
More informationAssurance Engagements Other than Audits or Review of Historical Financial Statements
Issued December 2007 International Standard on Assurance Engagements Assurance Engagements Other than Audits or Review of Historical Financial Statements The Malaysian Institute Of Certified Public Accountants
More informationInternational Standard on Auditing (UK) 530
Standard Audit and Assurance Financial Reporting Council June 2016 International Standard on Auditing (UK) 530 Audit Sampling The FRC s mission is to promote transparency and integrity in business. The
More informationSRI LANKA AUDITING STANDARD 530 AUDIT SAMPLING CONTENTS
SRI LANKA AUDITING STANDARD 530 AUDIT SAMPLING (Effective for audits of financial statements for periods beginning on or after 01 January 2014) CONTENTS Paragraph Introduction Scope of this SLAuS... 1
More informationSAS 112: Communicating Internal Control Related Matters Identified in an Audit
SAS 112: Communicating Internal Control Related Matters Identified in an Audit Effective: NOW!!! For audits of financial statements for periods ending on or after December 15, 2006. SAS 112 Requires the
More informationAuditing Standards and Practices Council
Auditing Standards and Practices Council Philippine Standard on Assurance Engagements 3000 (Revised) ASSURANCE ENGAGEMENTS OTHER THAN AUDITS OR REVIEWS OF HISTORICAL FINANCIAL INFORMATION PHILIPPINE STANDARD
More informationRULES OF CONDUCT OF INSIDERS RESPECTING
T RULES OF CONDUCT OF INSIDERS RESPECTING RADING O F SECURITIES OF TFI International lnc. Amended and restated July 2015 Executive Summary As an insider of TFI International Inc. ( TFI International )
More informationDIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM
November 28, 2017 DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM Dr. Jürgen Wunram Agenda Diebold Nixdorf AG History and shareholder structure Market trends, strategy and progress of integration Diebold Nixdorf
More informationMIAMI CHILDREN S HOSPITAL POLICY AND PROCEDURE
ISSUED BY: Research PAGE: 1 of 6 REPLACES POLICY DATED: EFFECTIVE DATE: 08/09/2012 DISTRIBUTION: Departmentwide APPROVED BY: Andrews, April (SVP/CECO), BOD Audit and Compliance Committee, Perdomo, Jose
More informationAnalysis of Responses to Question 5 of the Exposure Draft
Agenda Item 2-F.3 Analysis of Responses to Question 5 of the Exposure Draft Section I: Question included in Exposure Draft 1. The following question was asked in the Exposure Draft: 5. Does the requirement
More informationT H O M A S J. R A Y. May 15, International Auditing and Assurance Standards Board 529 5th Avenue New York, New York 10017
T H O M A S J. R A Y AUDITCHIEF@GMAIL.COM NEW YORK, NEW YORK May 15, 2016 International Auditing and Assurance Standards Board 529 5th Avenue New York, New York 10017 Re: Invitation to Comment: Enhancing
More informationOperational Efficiency:
Operational Efficiency: metrics that matter Copyright Altus Ltd 214. All rights reserved. Kevin Okell Consultancy Director 15/5/214 From distribution chain to value chain Ad-valorem pricing driven from
More informationDON M. PALLAIS, CPA 14 Dahlgren Road Richmond, Virginia Telephone: (804) Fax: (804)
DON M. PALLAIS, CPA 14 Dahlgren Road Richmond, Virginia 23233 Telephone: (804) 784-0884 Fax: (804) 784-0885 Office of the Secretary PCAOB 1666 K Street, NW Washington, DC 20006-2083 Gentlemen: November
More informationBasis for Conclusions: ISA 230 (Redrafted), Audit Documentation
Basis for Conclusions: ISA 230 (Redrafted), Audit Documentation Prepared by the Staff of the International Auditing and Assurance Standards Board December 2007 , AUDIT DOCUMENTATION This Basis for Conclusions
More informationINTERNATIONAL STANDARD ON AUDITING (NEW ZEALAND) 530
Issued 07/11 INTERNATIONAL STANDARD ON AUDITING (NEW ZEALAND) 530 Audit Sampling (ISA (NZ) 530) Issued July 2011 Effective for audits of historical financial statements for periods beginning on or after
More informationAUDIT SAMPLING CHAPTER LEARNING OUTCOMES CHAPTER OVERVIEW
CHAPTER 7 AUDIT SAMPLING After studying this chapter, you will be able to: LEARNING OUTCOMES Define Audit Sampling as per Standards on Auditing 530 and it importance. Identify the Approaches to Audit Sampling
More informationDeloitte Touche Tohmatsu ABN 74 490 121 060 Eclipse Tower 60 Station Street Parramatta Sydney, NSW, 2150 Australia Phone: +61 2 9840 7000 www.deloitte.com.au The Board of Directors The Deaf Society Level
More informationSumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical
For immediate release November 25, 2004 Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical Sumitomo Chemical Co., Ltd. announced today that its subsidiary, Sumitomo
More informationInternational Framework for Assurance Engagements
FRAMEWORK March 2015 Framework International Framework for Assurance Engagements Explanatory Foreword The Council of the Malaysian Institute of Accountants has approved this International Framework for
More informationMANAGEMENT. MGMT 0021 THE MANAGEMENT PROCESS 3 cr. MGMT 0022 FINANCIAL ACCOUNTING 3 cr. MGMT 0023 MANAGERIAL ACCOUNTING 3 cr.
MANAGEMENT MGMT 0021 THE MANAGEMENT PROCESS 3 cr. An introduction designed to emphasize the basic principles, practices, and terminology essential to the understanding of contemporary business and its
More informationFor personal use only
HY18 Result Presentation 13 February 2018 Dig Howitt Brent Cubis CEO & President CFO HY18 Result highlights Strong momentum across developed markets continues Developed market unit growth up 12% Strengthening
More information******************************************************************* MINUTES OF SYMMES TOWNSHIP SPECIAL MEETING
******************************************************************* MINUTES OF SYMMES TOWNSHIP SPECIAL MEETING AUGUST 14, 2018 ******************************************************************* The meeting
More informationIAASB Main Agenda (March 2005) Page Agenda Item. DRAFT EXPLANATORY MEMORANDUM ISA 701 and ISA 702 Exposure Drafts February 2005
IAASB Main Agenda (March 2005) Page 2005 579 Agenda Item 13-F DRAFT EXPLANATORY MEMORANDUM ISA 701 and ISA 702 Exposure Drafts February 2005 Introduction This memorandum provides some background to, and
More informationDRAFT FOR PUBLIC COMMENT Guidance Note for ESS9 Financial Intermediaries
The Guidance Notes provide guidance for the Borrower on the application of the Environmental and Social Standards (ESSs), which form part of the World Bank s 2016 Environmental and Social Framework. The
More informationXXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology
Company Update Industrial & Consumer Technology (XXII - $2.81 - Buy) COMPANY NOTE JAMES McILREE, CFA, Senior Research Analyst, +1-646-465-9034 jmcilree@chardan.com Sales and trading 7 a.m. to 7 p.m. ET,
More informationAssurance Engagements Other Than Audits or Reviews of Historical Financial Information
SINGAPORE STANDARD ON ASSURANCE ENGAGEMENTS SSAE 3000 (Revised) Assurance Engagements Other Than Audits or Reviews of Historical Financial Information The Singapore Standard on Auditing (SSA) 100 Assurance
More informationCMS Issues Revised Outlier Payment Policy. By John V. Valenta
CMS Issues Revised Outlier Payment Policy By John V. Valenta Editor s note: John V. Valenta is a senior manager with Deloitte & Touche. He may be reached in Los Angles, CA at 213/688-1877 or by email at
More informationThis is a licensed product of Ken Research and should not be copied
1 TABLE OF CONTENTS 1. The US Diabetes Care Devices Market Introduction 1.1. What is Diabetes and it s Types? 2. The US Diabetes Care Devices Market Size, 2007-2013 3. The US Diabetes Care Devices Market
More informationSmart Campaign Certification Standards
Smart Campaign Certification Standards January 2013 ww Client Protection Certification standards describe where the microfinance industry sets the bar in terms of client protection. To be Certified, a
More informationNORTH AMERICAN DERMATOLOGY. M&A Activity and Valuation Trends Q Robert Ullman Managing Director
Robert Ullman Managing Director rullman@dinancapital.com 45.63.44 NORTH AMERICAN DERMATOLOGY M&A Activity and Valuation Trends Q4 205 William Downing Director wdowning@dinancapital.com 602.734.0682 Michael
More informationIAASB Exposure Draft, Proposed ISAE 3000 (Revised), Assurance Engagements Other Than Audits or Reviews of Historical Financial Information
Tel +44 (0) 20 7694 8871 Fax +44 (0) 20 7694 8429 8 Salisbury Square DX 38050 Blackfriars London EC4Y 8BB sylvia.smith@kpmgifrg.com United Kingdom Technical Director International Auditing and Assurance
More informationIs Your Sample Representative?
Is Your Sample Representative? Are You Sure? May 8, 2014 Beth A. Wood, CPA, North Carolina State Auditor 1 Is Your Sample Representative? Course Objectives Understand Some Fundamental Concepts of Sampling
More informationTRANSLATION. Montreal, April 11, 2011
TRANSLATION Montreal, April 11, 2011 Technical Director International Auditing and Assurance Standards Board 545 Fifth Avenue, 14 th Floor New York, New York 10017 USA Dear Madam/Sir: Please find enclosed
More informationESM MANAGEMENT COMMENTS ON BOARD OF AUDITORS ANNUAL REPORT TO THE BOARD OF GOVERNORS. for the period ended 31 December 2015
ESM MANAGEMENT COMMENTS ON BOARD OF AUDITORS ANNUAL REPORT TO THE BOARD OF GOVERNORS for the period ended 31 December 2015 2 EUROPEAN STABILITY MECHANISM Dear Chairperson, I would like to thank you for
More information15 May 2017 Exposure Draft. Response Due Date 23 June Exposure Draft
15 May 2017 Exposure Draft Response Due Date 23 June 2017 Exposure Draft Proposed Application Material Relating to: (a) Professional Skepticism Linkage with the Fundamental Principles; and (b) Professional
More informationCommitted to Environment, Health and Safety
Committed to Environment, Health and Safety Environment, Health and Safety Management System and Policy of GCP Applied Technologies Inc. SEPTEMBER 1, 2017 The GCP Environment, Health, and Safety Management
More informationHILLENBRAND INDUSTRIES INC
HILLENBRAND INDUSTRIES INC FORM 8-K (Unscheduled Material Events) Filed 2/17/2004 For Period Ending 2/13/2004 Address 700 STATE ROUTE 46 E BATESVILLE, Indiana 47006-8835 Telephone 812-934-7000 CIK 0000047518
More informationDainippon Pharmaceutical and Sumitomo Pharmaceuticals Finalize Merger Agreement
For immediate release April 28, 2005 Dainippon Pharmaceutical and Sumitomo Pharmaceuticals Finalize Merger Agreement Dainippon Pharmaceutical Co., Ltd. Sumitomo Pharmaceuticals Co., Ltd. Dainippon Pharmaceutical
More informationReport for the fourth quarter of 2016 and subsequent events (Un-audited)
SERODUS ASA Report for the fourth quarter of 2016 and subsequent events (Un-audited) Oslo, 27 February 2017 04-17 2016 Q4 report ABOUT SERODUS Serodus has been delisted from Oslo Axess and is now a private
More informationClient Responses to Non-Compliant Audits: An Analysis of Clients Targeted by PCAOB Inspection
University of Tennessee, Knoxville Trace: Tennessee Research and Creative Exchange Doctoral Dissertations Graduate School 5-2014 Client Responses to Non-Compliant Audits: An Analysis of Clients Targeted
More informationCommitted to Environment, Health, & Safety
Committed to Environment, Health, & Safety Environment, Health, and Safety Management System and Policy of W. R. Grace & Co. November 8, 2018 The Grace Environment, Health, and Safety Management System,
More informationHow can EHS management help reduce your enterprise risk?
How can EHS management help reduce your enterprise risk? October 2017 The better the question. The better the answer. The better the world works. Contents 1 2 How can EHS management help reduce your enterprise
More informationEnvironmental, Health and Safety
Environmental, Health and Safety Codes of Practice The Environmental, Health and Safety (EHS) Codes of Practice set forth Zimmer EHS requirements for our business functions and facilities worldwide. In
More informationNeuroscience at Deloitte Growing a network that fires and wires together
Neuroscience at Deloitte Growing a network that fires and wires together Neuroscience at Deloitte Most decisions are made unconsciously. Thoughts and feelings shape decisions as well as interactions between
More informationHyundai Motor Company 1 st Quarter 2011 Business Results. April 28, 2011
Hyundai Motor Company 1 st Quarter 2011 Business Results April 28, 2011 Cautionary Statement with Respect to Forward-Looking Statements In the presentation that follows and in related comments by Hyundai
More informationAcquisition of Novartis Influenza Vaccines Business. 27 th October 2014
1 Acquisition of Novartis Influenza Vaccines Business 27 th October 2014 2 Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials, and include
More informationInterim Report 1 January September 2017
2014-01-01 2014-12 Interim Report 1 January 2017 30 September 2017 Cantargia AB 556791-6019 Cantargia refers to Cantargia AB (publ), corporate ID number 556791-6019. Clinical trial initiated Highlights
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION May 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities regulation.
More informationTHE STATE OF THE MEDICAL MARIJUANA MARKETS 2011
THE STATE OF THE MEDICAL MARIJUANA MARKETS 2011 MEDICAL MARIJUANA MARKETS 2011 @2010 Shutterstock, All Rights Reserved. Sponsored by See Change Strategy is an independent financial news and information
More informationM e d i a s e t G r o u p
M e d i a s e t G r o u p 11 th May 2004 2004 First Quarter Results M e d i a s e t G r o u p BROADCASTING MEDIASET 2004 1Q 24 Hours Audience Trend Individuals Share Points Vs 1Q 2003 OTHER SATELLITE 44.0%
More informationST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015
ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015 1 FORWARD LOOKING STATEMENT This presentation contains forward-looking statements within the meaning of the Private Securities Litigation
More informationPlanning For The FDA s 'Deeming Rule' For E- Cigarettes
Law360, New York (September 21, 2015, 3:39 PM ET) -- The 2009 Family Smoking Prevention and Tobacco Control Act (TCA)[1] gave the U.S. Food and Drug Administration the authority to oversee the manufacture,
More informationInvestor Presentation
ASX:THC B u i l d i n g a M e d i c i n a l C a n n a b i s B u s i n e s s Investor Presentation November 2017 DISCLAIMER The material in this presentation (material) is not and does not constitute an
More informationBVI Limited Partnership Hedge Funds: Calling Japan
BERMUDA BRITISH VIRGIN ISLANDS CAYMAN ISLANDS CYPRUS DUBAI HONG KONG LONDON MAURITIUS MOSCOW SÃO PAULO SINGAPORE conyersdill.com June 2012 BVI Limited Partnership Hedge Funds: Calling Japan Structuring
More informationMANDATORY EMPHASIS PARAGRAPHS, CLARIFYING LANGUAGE, AND JUROR ASSESSMENTS OF AUDITOR LIABILITY
MANDATORY EMPHASIS PARAGRAPHS, CLARIFYING LANGUAGE, AND JUROR ASSESSMENTS OF AUDITOR LIABILITY Brian Goodson Doctoral Student Patterson School of Accountancy The University of Mississippi University, MS
More informationThe Incremental Effects of Fraud and Going-concern Risk on Audit Procedures. Allen D. Blay University of California, Riverside
The Incremental Effects of Fraud and Going-concern Risk on Audit Procedures Allen D. Blay University of California, Riverside Tim Kizirian Craig and Joan Young Professor of Accounting California State
More informationManagementStudyGuide.com. Visit https://grandemareopenseatoknowledge.wordpress.com/
BCG Matrix Contents? Emergence of BCG Matrix Approaches of BCG Matrix Components of BCG Matrix Applications of BCG Matrix Advantages of BCG Matrix Limitations of BCG Matrix Emergence of Portfolio Matrices
More informationInvestor Presentation
Investor Presentation February 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities
More informationLeveraging Technology for the Canadian Private Target Mergers & Acquisitions Deal Points Study
Osler, Hoskin & Harcourt LLP Leveraging Technology for the Canadian Private Target Mergers & Acquisitions Deal Points Study ABA MARKET TRENDS COMMITTEE MEETING André Perey Natalie Munroe March 2019 Background
More informationMental Toronto Hydro
Mental Health @ Shirley Powell, Director, HR Planning, Systems & Rewards Benefits Canada s 2015 Healthy Outcomes Conference June 9-11, 2015 Niagara-on-the-Lake Company Overview Established in 1911 Largest
More informationFor personal use only
Virtus Health (ASX. VRT) Sue Channon CEO and Glenn Powers CFO Navigating Future Growth, UBS Australasian Conference 7 November, 2016 DISCLAIMER 2 The material in this presentation has been prepared by
More informationGrowth in core businesses offsets weaker non-interest income. DBS Group Holdings 1Q 2005 Financial Results Presentation to Media and Analysts
Growth in core businesses offsets weaker non-interest income April 29, 2005 DBS Group Holdings 1Q 2005 Financial Results Presentation to Media and Analysts This presentation is available at www.dbs.com/investor
More informationView Report Details. Global Coronary Stent Market
View Report Details Global Coronary Stent Market ------------------------------------------------- 2013 View Report Details Executive Summary Coronary heart diseases are nowadays becoming more and more
More information14 February Tower Old Broad Street London EC2N 1HQ United Kingdom t + 44 (0) f + 44 (0)
14 February 2008 Jim Sylph International Auditing and Assurance Standards Board 545 5th Avenue, 14th Floor New York, New York 10017 USA Edcomments@ifac.org Tower 42 25 Old Broad Street London EC2N 1HQ
More informationThe Portuguese Non-Observed Economy: Brief Presentation
The Portuguese Non-Observed Economy: Brief Presentation Note: this document presents a summary of the research developed by Nuno Gonçalves, under the orientation of Oscar Afonso, both members of the Observatório
More informationTPN Investment Adviser Written Supervisory Procedures. December 2006
TPN Investment Adviser Written Supervisory Procedures December 2006 TABLE OF CONTENTS I. Introduction 1 A. Compliance Program Policy 1 1. Compliance Program 2. Compliance Manual 3. Chief Compliance Officer
More informationUNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK. ) Case No.
PLAINTIFF, Individually and On Behalf of All Others Similarly Situated, v. UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK Case No. Plaintiff, GW PHARMACEUTICALS PLC, JUSTIN D. GOVER, and ADAM
More informationEarly Evidence on the Effects of Critical Audit Matters on Auditor Liability
CURRENT ISSUES IN AUDITING Vol. 10, No. 1 Spring 2016 pp. A24 A33 American Accounting Association DOI: 10.2308/ciia-51369 Early Evidence on the Effects of Critical Audit Matters on Auditor Liability Christine
More informationGeneral Terms and Conditions
General Terms and Conditions Revision history (November 2007) Date issued Replaced pages Effective date 11/07 ii, iii, 2, 4 11/07 11/06 all pages 11/06 01/06 all pages 01/06 02/05 ii, iii, 4, 7 8 02/05
More information545 Fifth Avenue, 14th Floor Tel: +1 (212) New York, New York Fax: +1 (212) Internet:
Committee INTERNATIONAL FEDERATION OF ACCOUNTANTS 545 Fifth Avenue, 14th Floor Tel: +1 (212) 286-9344 New York, New York 10017 Fax: +1 (212) 856-9420 Internet: http://www.ifac.org Ethics Committee Meeting
More information9-A ISA 260 (Revised and Redrafted) Significant Issues
IAASB Main Agenda (September 2007) Page 2007 2777 Agenda Item 9-A ISA 260 (Revised and Redrafted) Significant Issues NOTE: Paragraph references written as (old) are to paragraph numbers as they appeared
More informationUnmasking India s NPA issues can the banking sector overcome this phase?
Unmasking India s NPA issues can the banking sector overcome this phase? Contents Executive summary...2 Is the NPA crisis just the tip of the iceberg?...3 Triggers leading to the NPA predicament...4 Restructuring
More informationGeneral Terms and Conditions
General Terms and Conditions Revision history (July 2008) Date issued Replaced pages Effective date 07/08 all pages 07/08 11/07 ii, iii, 2, 4 11/07 11/06 all pages 11/06 01/06 all pages 01/06 02/05 ii,
More informationCognitive Fallacies in Group Settings. Daniel O Leary University of Southern California
Cognitive Fallacies in Group Settings Daniel O Leary University of Southern California From: AAAI Technical Report SS-94-07. Compilation copyright 1994, AAAI (www.aaai.org). All rights reserved. Abstract
More informationAudit Firm Administrator steps to follow
Contents Audit Firm Administrator steps to follow... 3 What to know before you start... 3 Understanding CaseWare Cloud in a nutshell... 3 How to do the once off set up for the Audit Firm or Organisation...
More informationAnnual Report of Estyn s Audit and Risk Assurance Committee
Annual Report of Estyn s Audit and Risk Assurance Committee 1 Purpose 1.1 This report summarises the main work of the Estyn Audit and Risk Assurance Committee during the period 1 st April 2013 31 st March
More informationCENTRALE. Monetary. compared. domestic. million.
CENTRALE BANK VAN ARUBAA Statistical News Release Second Quarter 2012 Date: November 7, 2012 Monetary and financial developments Money and credit In the second quarterr of 2012, the money supply decreased
More informationBEFORE THE PUBLIC UTILITY COMMISSION OF OREGON
ORDER NO. t8 ENTERED FEB 0 2 2018 BEFORE THE PUBLIC UTILITY COMMISSION OF OREGON LC66 In the Matter of PORTLAND GENERAL ELECTRIC COMPANY, ORDER 2016 Integrated Resource Plan. DISPOSITION: 2016 IRP REVISED
More informationSurvey of local governors associations 2014
Survey of local governors associations 2014 Thank you to the 30 local associations that took part in our survey. This represents just under half of the local associations who are in membership of National
More informationBasis for Conclusions: ISA 500 (Redrafted), Audit Evidence
Basis for Conclusions: ISA 500 (Redrafted), Audit Evidence Prepared by the Staff of the International Auditing and Assurance Standards Board December 2008 , AUDIT EVIDENCE This Basis for Conclusions has
More informationData collection, summarizing data (organization and analysis of data) The drawing of inferences about a population from a sample taken from
1 Nature of Statistics The Study of statistics involves; Data collection, summarizing data (organization and analysis of data) and interpretation of data. The drawing of inferences about a population from
More informationThe Cigarette Market in Greece
The Cigarette Market in Greece Product Code: CG0145MR Published Date: April 2015 Report Price: US$ 975 (Single Copy) Synopsis Cigarettes in Greece report is a qualitative report providing extensive and
More informationCommunity Benefits and the New Form 990
Community Benefits and the New Form 990 Anne McGeorge Grant Thornton LLP Grant Thornton LLP. All rights reserved. anne.mcgeorge@gt.com (704) 632-3520 May 7, 2008 Why Form 990 is important The public: Maintaining
More informationPRICE DEMERS & CO. Barristers, Solicitors & Notaries Public
PRICE DEMERS & CO. Barristers, Solicitors & Notaries Public Incorporation of BVI Business Companies under the BVI Business Companies Act, 2004 1. Introduction The following is a brief summary of the main
More informationDIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC)
DIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC) R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p
More informationFiona Campbell. ISA 315 (Revised) Responding to Comments to the Exposure Draft. Deputy Chair of the IAASB and Chair of the ISA 315 Task Force
ISA 315 (Revised) Responding to Comments to the Exposure Draft IAASB Meeting March 12 th, 2019 Fiona Campbell Deputy Chair of the IAASB and Chair of the ISA 315 Task Force Responses to ED-315 Broad concerns
More informationCraft Personality Questionnaire
Craft Personality Questionnaire Evidence of Reliability and Validity 888-298-6227 TalentLens.com Copyright 2008 Pearson Education, Inc., or its affiliates. All rights reserved. Copyright 2008 by Pearson
More informationMinistry of Children and Youth Services. Follow-up to VFM Section 3.01, 2013 Annual Report RECOMMENDATION STATUS OVERVIEW
Chapter 4 Section 4.01 Ministry of Children and Youth Services Autism Services and Supports for Children Follow-up to VFM Section 3.01, 2013 Annual Report RECOMMENDATION STATUS OVERVIEW # of Status of
More informationSoca Music: A competitive cultural tourism product?
Soca Music: A competitive cultural tourism product? Can the soca music cultural asset be transformed into an internationally competitive cultural tourism product? Presentation Outline Introduction/Background
More informationSlide 1. Financial update and closing remarks. Jesper Brandgaard EVP and CFO. RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A
Slide 1 Financial update and closing remarks Jesper Brandgaard EVP and CFO RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A Slide 2 Forward-looking statements Novo Nordisk s reports filed with or
More information1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes
1Q 2015 Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes Forward-Looking Statements and Copyright This Presentation includes and is based, inter alia, on forward-looking information and statements
More informationJanuary 30, 2018 Dow Wilson President and Chief Executive Officer
Acquisition of SIRTeX January 30, 2018 Dow Wilson President and Chief Executive Officer This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Forward-Looking
More informationStandards, Education, Verification. Patient Focused Certification
Standards, Education, Verification Patient Focused Certification PFC Training helps you achieve quality standards. Staff Certification is now available online www.pfctraining.org jahan@safeaccessnow.org
More informationFIRSTQUARTER2018 RESULTSPRESENTATION
FIRSTQUARTER2018 RESULTSPRESENTATION May 14 th 2018 Juan Lladó CEO 1 DISCLAIMER This document has been prepared by Técnicas Reunidas S.A. (the Company) solely for use at presentations held in connection
More informationZacks Small-Cap Research
Zacks Small-Cap Research Sponsored Impartial - Comprehensive August 29, 2018 David Bautz, PhD 312-265-9471 dbautz@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Opiant Pharmaceuticals,
More informationMINUTES OF THE ANNUAL SOLVAY S.A. SHAREHOLDERS MEETING On Tuesday, May 10, 2016 at 10:30 a.m.
MINUTES OF THE ANNUAL SOLVAY S.A. SHAREHOLDERS MEETING On Tuesday, May 10, 2016 at 10:30 a.m. The shareholders of the company Solvay S.A. with its corporate offices in Brussels, rue de Ransbeek, no. 310,
More information